Intelligence · Clinical Development
Pipeline search results
Programs matching “prostate-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 133 pipeline programs matching "prostate-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Rezvilutamide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metastatic Hormone-Sensitive Prostate Cancer
1 trial -
SRF617
Arcus Biosciences
Metastatic Castration-resistant Prostate Cancer
1 trial -
SX-682
United Therapeutics Europe Ltd
Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Prostate Cancer
1 trial -
Steroids switch
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
TAK-385
Takeda
Prostate Cancer
1 trial -
TAK-700
Takeda
Prostate Cancer
1 trial -
Testosterone Enanthate 100 MG/ML Injectable Solution
Hospital Authority, Hong Kong
Castration-resistant Prostate Cancer
1 trial -
Testosterone cypionate
United Therapeutics Europe Ltd
Castration Resistant Metastatic Prostate Cancer
1 trial -
Zoladex
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
aglatimagene besadenovec
Candel Therapeutics
Prostate Cancer
1 trial -
aglatimagene besadenovec + valacyclovir
Candel Therapeutics
Prostate Cancer Patients Treated by Radiotherapy
1 trial -
177Lu-DOTA-TLX591
Telix Innovations
Metastatic Prostate Cancer
1 trial -
2mg INO-5150 and electroporation device CELLECTRA®-5P
INOVIO PHARMACEUTICALS, INC.
Prostate Cancer
1 trial -
64Cu-DOTA-TLX592
Telix Innovations
Metastatic Prostate Cancer
1 trial -
68Ga-AAZTA-NI-093
The First People's Hospital of Lianyungang
Prostate Cancer (Adenocarcinoma)
1 trial -
68Ga-PSMA-11
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
89Zr-DFO-YS5
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
99mTc-QULIC-5-P1
The First People's Hospital of Lianyungang
Prostate Cancer Stage
1 trial -
AMG 509
BEONE MEDICINES AUS PTY LTD
Prostate Cancer
1 trial -
AZD3514
AstraZeneca
Prostate Cancer
1 trial -
BMS-641988 (AR#2)
Bristol-Myers Squibb
Prostate Cancer
1 trial -
BPX-601
Regeneron UK Limited
Prostate Cancer
1 trial -
BPX-601
Regeneron UK Limited
Metastatic Castration-resistant Prostate Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.